Hypertension Drugs Industry Forecasts

Hypertension Drugs Industry Forecasts - China Focus

Publication ID:

AMID1019069

Publication Date:

October 11, 2019

Pages:

109

Publisher:

Asia 麻豆原创 Information & Development Co.

Countries:

China [1]

USD 1,800.00

Pharmaceutical Manufacturing [2]

Pharma & Healthcare [3]

Description:

This study focuses on China鈥檚 Hypertension Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China鈥檚 society and economy. China is one of the world鈥檚 major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world鈥檚 fastest growing market for the consumptions of goods and services. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market.

Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector鈥檚 economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products.

This new study focuses on industry trends and forecasts with historical data (2008, 2013 and 2018) and long-term forecasts through 2023 and 2028 are presented.
The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments鈥� industry bureaus, industry publications, and our in-house databases.

Asia 麻豆原创 Info & Dev Co. is one of the leading sources for up-to-date market information and research on the fastest-growing Chinese markets. We have published over 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our publications are intended to help international marketers identify business opportunities and promote their product sales in the Chinese markets.

Table Of Contents:

TABLE OF CONTENTS

I. INTRODUCTION

Report Scope and Methodology
Executive Summary

II. BUSINESS ENVIRONMENT

Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties
麻豆原创 Trends
Technology Development
麻豆原创 Development
Major Industry Development
Regional Development
Enterprise Development
Labor 麻豆原创 Development

IV. HYPERTENSION DRUGS PRODUCTION AND DEMAND

麻豆原创 Overview by Drugs Classification

Calcium Channel Blocker
Felodipine
Nifedipine
Amlodipine
Nisoldipine
Nimodipine
Nitrendipine
Angiotensin 鈪� Receptor Antagonists Drug
Losartan
Valsartan
Irbesartan
Telmisartan
Candesartan
Angiotensin-Converting Enzyme Inhibitor
Benazepril
Enalapril
Captopril
Lisinopril
Ramipril
Other Hypertension Drugs
Import and Export
麻豆原创 Overview by Producers
Pricing Trend

LIST OF TABLES

I. INTRODUCTION

Economic Outlook Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade

IV. HYPERTENSION DRUGS PRODUCTION AND DEMAND

Hypertension Drugs Sales Volume by Drugs Classification
Calcium Channel Blocker Sales Volume and 麻豆原创 Share by Drugs Classification
Angiotensin 鈪� Receptor Antagonists Drug Sales Volume and 麻豆原创 Share by Drugs Classification
Angiotensin-Converting Enzyme Inhibitor Sales Volume and 麻豆原创 Share by Drugs Classification
Other Hypertension Drugs Sales Volume and 麻豆原创 Share by Drugs Classification
Hypertension Drugs Import by Drugs Classification
Hypertension Drugs Export by Drugs Classification
Hypertension Drugs Major Producer, Sales Volume, and 麻豆原创 Share

LIST OF CHARTS

I. INTRODUCTION

Hypertension Drugs Sales Volume

II. BUSINESS ENVIRONMENT

China鈥檚 GDP and Growth Rate
Industrial Output by Ownership
China鈥檚 Imports and Exports

IV. HYPERTENSION DRUGS PRODUCTION AND DEMAND

Hypertension Drugs Sales Volume
Hypertension Drugs Import
Hypertension Drugs Export
Hypertension Drugs Sales Volume by Drugs Classification
Calcium Channel Blocker Sales Volume and 麻豆原创 Share
Calcium Channel Blocker 麻豆原创 Share by Drugs Classification
Angiotensin 鈪� Receptor Antagonists Drug Sales Volume and 麻豆原创 Share
Angiotensin 鈪� Receptor Antagonists Drug 麻豆原创 Share by Drugs Classification
Angiotensin-Converting Enzyme Inhibitor Sales Volume and 麻豆原创 Share
Angiotensin-Converting Enzyme Inhibitor 麻豆原创 Share by Drugs Classification
Other Hypertension Drugs Sales Volume and 麻豆原创 Share
Other Hypertension Drugs 麻豆原创 Share by Drugs Classification
Hypertension Drugs Import by Drugs Classification
Calcium Channel Blocker Import and 麻豆原创 Share
Angiotensin 鈪� Receptor Antagonists Drug Import and 麻豆原创 Share
Angiotensin-Converting Enzyme Inhibitor Import and 麻豆原创 Share
Other Hypertension Drugs Import and 麻豆原创 Share
Hypertension Drugs Export by Drugs Classification
Calcium Channel Blocker Export and 麻豆原创 Share
Angiotensin-Converting Enzyme Inhibitor Export and 麻豆原创 Share
Angiotensin 鈪� Receptor Antagonists Drug Export and 麻豆原创 Share
Other Hypertension Drugs Export and 麻豆原创 Share

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.